
Medical information service alerts U.S. physicians to Raptiva recall within hours

No. 3 pharmacy benefits manager to swallow No. 4

New unit will ship from La Vergne, TN specialty-care products warehouse

Second annual survey solidifies understanding of consumer segments

But, AHRQ data show that e-prescribing systems can hurt branded-pharma sales

Real-time web mining technology gathers data for use by legal and federal entities

Cambridge Consultants expects DPI use to expand into new treatment areas

New group of injectables manufacturers tussles with USP over use of labeling ‘real estate’ on vial caps

Moving boxes is becoming just one of a growing slate of services from third-party logistics (3PL) providers

Mature product franchises and mixed clinical outcomes have not dissuaded pharma companies from expending marketing resources for cardiovascular disease treatment

Surveys from SDI and Market Strategies International score companies on their promotional practices and business relationships

Expect a flood of product-liability suits in the aftermath of Wyeth vs. Levine

Two prefilled-syringe projects emphasize user friendliness

Optimized dimensionality is the goal of new products from MTS and Cold Chain Technologies

Unified corporate image emphasizes supply chain services

American Recovery and Reinvestment Act allocates $18 billion for HIT

Contract packagers are multiplying their product offerings to meet marketing and patient-safety concerns



BIOPHARMA INDUSTRY

Relsys’ ‘structured signal management’ analyzes patient data for trends

DDN goes with Axway’s Trade Activity Manager; repackager Apace Packaging chooses Supplyscape’s Nexus platform

American Recovery and Reinvestment Act allocates $18 billion for HIT

Drugmakers face difficulty justifying expenses amid restrictions

Bipartisan group of senators sponsor a revived drug-importation bill

Although human trials in the U.S. are still a novelty, developers are identifying both sources and protocols for conducting therapy

Regulatory attention has intensified over commercial activities. Here’s what to do to minimize risks and raise compliance levels


The studio model: how film industry practices can boost pharmaceutical creativity

While track-and-trace initiatives stumble along, more technology firms provide authentication solutions